Financials

  • Market Capitalization 9.08 B
  • Employee 253
  • Founded 2015
  • CEO N/A
  • Website www.kymeratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDHC8D1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-21.09
Relación precio/flujo de caja
167.66

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
948
IONS
Ionis Pharmaceuticals, Inc. - Common Stock
56.75 USD-2.58%-32.78%-22.78%-21.32%9.38 B USD
959
CORT
Corcept Therapeutics Incorporated - Common Stock
85.90 USD-6.51%-6.98%+3.61%+17.08%9.22 B USD
968
HALO
Halozyme Therapeutics, Inc. - Common Stock
76.11 USD-0.12%-6.56%+8.54%+13.94%9.03 B USD
983
CRNX
Crinetics Pharmaceuticals, Inc. - Common Stock
83.67 USD+0.11%+0.11%+141.96%+103.58%8.82 B USD

Noticias